How Do Experience And Capacity Impact Oral Dose Outsourcing?

In Q2 2018, ISR asked 44 outsourcers of oral solid dose drug product manufacturing to select from four different reasons that manufacturing may be split between in-house and external resources. The data below show how respondents rated their organization’s experience and capacity with respect to outsourcing oral solid dose products, like tablets. The majority (48%) stated their company has adequate experience but lacks manufacturing capacity.